Profile picture

Doctor Luigi Adamo

Washington University, St Louis (United States of America)
Follow
Biography
Dr Luigi Adamo is a heart failure specialist and a physician-scientist in the Center for Cardiovascular Research at Washington University in St Louis. After graduating from University of Palermo Medical School (Italy), Dr Adamo moved to the US to complete a PhD in Biology and Biomedical Sciences at Harvard University. Afterwards, he was recruited to Washington University in St Louis where he completed Internal Medicine Residency, Cardiology Fellowship, Advanced Heart Failure Fellowship and finally post-doctoral training in the group of Dr Doug Mann. Dr Adamo's clinical research focuses on heart failure with recovered ejection fraction and patient selection for durable mechanical circulatory support. Dr Adamo's basic research focuses on inflammation in heart failure.
Logo ESC

Contributor content

Global longitudinal strain predicts future cardiovascular hospitalizations and death in patients with non-ischemic cardiomyopathy and recovered left ventricular ejection fraction: a multicenter study
Presentation
Global longitudinal strain predicts future cardiovascular hospitalizations and death in patients with non-ischemic cardiomyopathy and recovered left ventricular ejection fraction: a multicenter study
Plasma proteome analysis of patients with heart failure identifies HFmrEF with unimproved EF as an intermediate state between HFpEF and HFrEF, HFmrEF with improved EF as a distinct biological state
Presentation
Plasma proteome analysis of patients with heart failure identifies HFmrEF with unimproved EF as an intermediate state between HFpEF and HFrEF, HFmrEF with improved EF as a distinct biological state
The heart mate risk score identifies patients with similar mortality risk across all INTERMACS classes in a large multicenter analysis: low INTERMACS class should not be a contraindication to LVAD
Presentation
The heart mate risk score identifies patients with similar mortality risk across all INTERMACS classes in a large multicenter analysis: low INTERMACS class should not be a contraindication to LVAD

ESC 365 is supported by